Louise N. Johnson - Publications

Molecular Biophysics University of Oxford, Oxford, United Kingdom 
x-ray crystallography

178 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Johnson L, Igoe E, Kleftouris G, Papachristos IV, Papakostidis C, Giannoudis PV. Physical Health and Psychological Outcomes in Adult Patients with Long-bone Fracture Non-unions: Evidence Today. Journal of Clinical Medicine. 8. PMID 31731803 DOI: 10.3390/jcm8111998  0.01
2019 Johnson L, Burridge J, Demain S, Ewings S. Comparing the Impact of an Implicit Learning Approach With Standard Care on Recovery of Mobility Following Stroke: Protocol for a Pilot Cluster Randomized Controlled Trial. Jmir Research Protocols. 8: e14222. PMID 31687935 DOI: 10.2196/14222  0.01
2019 Smithen DA, Leung L, Challinor M, Lawrence R, Tang H, Niculescu-Duvaz D, Pearce SP, Mcleary R, Lopes F, Aljarah M, Brown M, Johnson L, Thomson G, Marais R, Springer C. 2-Aminomethylene-5-Sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth. Journal of Medicinal Chemistry. PMID 31430136 DOI: 10.1021/acs.jmedchem.9b01112  0.01
2017 Girotti MR, Lopes F, Preece N, Niculescu-Duvaz D, Zambon A, Davies L, Whittaker S, Saturno G, Viros A, Pedersen M, Suijkerbuijk BM, Menard D, McLeary R, Johnson L, Fish L, et al. Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma. Cancer Cell. 31: 466. PMID 28292443 DOI: 10.1016/J.Ccell.2017.02.007  0.01
2015 Johnson LN, Linder DE, Heinze CR, Kehs RL, Freeman LM. Evaluation of owner experiences and adherence to home-cooked diet recipes for dogs. The Journal of Small Animal Practice. PMID 26493128 DOI: 10.1111/jsap.12412  0.01
2015 Lyttle DP, Johnson LN, Margolin EA, Madsen RW. Levodopa as a possible treatment of visual loss in nonarteritic anterior ischemic optic neuropathy. Graefe's Archive For Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. PMID 26483145 DOI: 10.1007/s00417-015-3191-z  0.01
2015 Chan JL, Johnson LN, Efymow BL, Sammel MD, Gracia CR. Outcomes of ovarian stimulation after treatment with chemotherapy. Journal of Assisted Reproduction and Genetics. PMID 26400507 DOI: 10.1007/S10815-015-0575-2  0.01
2015 Johnson LN, Tambling RB, Mennenga KD, Ketring SA, Oka M, Anderson SR, Huff SC, Miller RB. Examining Attachment Avoidance and Attachment Anxiety Across Eight Sessions of Couple Therapy. Journal of Marital and Family Therapy. PMID 26255979 DOI: 10.1111/Jmft.12136  0.01
2015 Zak-Hunter L, Johnson LN. Exploring the Association Between Partner Behaviors and Eating Disorder Symptomology. Families, Systems & Health : the Journal of Collaborative Family Healthcare. PMID 26167623 DOI: 10.1037/fsh0000147  0.01
2015 Johnson LN, Heinze CR, Linder DE, Freeman LM. Evaluation of marketing claims, ingredients, and nutrient profiles of over-the-counter diets marketed for skin and coat health of dogs. Journal of the American Veterinary Medical Association. 246: 1334-8. PMID 26043131 DOI: 10.2460/javma.246.12.1334  0.01
2015 Johnson LN, McLeod BA, Burns LE, Arseneault K, Frasier TR, Broders HG. Population Genetic Structure Within and among Seasonal Site Types in the Little Brown Bat (Myotis lucifugus) and the Northern Long-Eared Bat (M. septentrionalis). Plos One. 10: e0126309. PMID 25942425 DOI: 10.1371/journal.pone.0126309  0.01
2015 Zak-Hunter L, Johnson LN. Exploring the Association Between Partner Behaviors and Eating Disorder Symptomology Families, Systems and Health. DOI: 10.1037/fsh0000147  0.01
2014 Johnson LN, Sammel MD, Dillon KE, Lechtenberg L, Schanne A, Gracia CR. Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception. Fertility and Sterility. 102: 774-781.e3. PMID 24934488 DOI: 10.1016/J.Fertnstert.2014.05.026  0.01
2014 Grotegut CA, Chisholm CA, Johnson LN, Brown HL, Heine RP, James AH. Medical and obstetric complications among pregnant women aged 45 and older. Plos One. 9: e96237. PMID 24769856 DOI: 10.1371/journal.pone.0096237  0.01
2014 Hillman JK, Johnson LN, Limaye M, Feldman RA, Sammel M, Dokras A. Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women with PCOS [corrected]. Fertility and Sterility. 101: 530-5. PMID 24382375 DOI: 10.1016/J.Fertnstert.2013.10.055  0.01
2013 Johnson LN, Sasson IE, Sammel MD, Dokras A. Does intracytoplasmic sperm injection improve the fertilization rate and decrease the total fertilization failure rate in couples with well-defined unexplained infertility? A systematic review and meta-analysis. Fertility and Sterility. 100: 704-11. PMID 23773312 DOI: 10.1016/J.Fertnstert.2013.04.038  0.01
2013 Johnson LN, Dillon KE, Sammel MD, Efymow BL, Mainigi MA, Dokras A, Gracia CR. Response to ovarian stimulation in patients facing gonadotoxic therapy. Reproductive Biomedicine Online. 26: 337-44. PMID 23415997 DOI: 10.1016/J.Fertnstert.2012.07.447  0.01
2012 Endicott JA, Noble ME, Johnson LN. The structural basis for control of eukaryotic protein kinases. Annual Review of Biochemistry. 81: 587-613. PMID 22482904 DOI: 10.1146/Annurev-Biochem-052410-090317  1
2012 Paglia MJ, Grotegut CA, Johnson LN, Thames B, James AH. Body mass index and severe postpartum hemorrhage. Gynecologic and Obstetric Investigation. 73: 70-4. PMID 21921570 DOI: 10.1159/000329335  0.01
2012 Johnson LN. Cell signalling through covalent modification and allostery Nato Science For Peace and Security Series a: Chemistry and Biology. 87-92. DOI: 10.1007/978-94-007-2530-0_8  1
2011 Grotegut CA, Paglia MJ, Johnson LN, Thames B, James AH. Oxytocin exposure during labor among women with postpartum hemorrhage secondary to uterine atony. American Journal of Obstetrics and Gynecology. 204: 56.e1-6. PMID 21047614 DOI: 10.1016/j.ajog.2010.08.023  0.01
2011 Johnson LN. Substrates of mitotic kinases Science Signaling. 4. DOI: 10.1126/scisignal.2002234  1
2010 Myatt D, Johnson L, Baumli S, Siligardi G. The binding of flavopiridol to blood serum albumin Chirality. 22: E40-E43. PMID 21038395 DOI: 10.1002/Chir.20925  1
2010 Baumli S, Endicott JA, Johnson LN. Halogen bonds form the basis for selective P-TEFb inhibition by DRB Chemistry and Biology. 17: 931-936. PMID 20851342 DOI: 10.1016/J.Chembiol.2010.07.012  1
2010 Duke EMH, Johnson LN. Macromolecular crystallography at synchrotron radiation sources: Current status and future developments Proceedings of the Royal Society a: Mathematical, Physical and Engineering Sciences. 466: 3421-3452. DOI: 10.1098/rspa.2010.0448  1
2010 Duke EMH, Evans G, Flaig R, Hall DR, Latchem M, McAuley KE, Sandy DJ, Sorensen TLM, Waterman D, Johnson LN. The phase I MX beamlines at diamond light source Aip Conference Proceedings. 1234: 165-168. DOI: 10.1063/1.3463165  1
2009 Johnson LN. The regulation of protein phosphorylation. Biochemical Society Transactions. 37: 627-41. PMID 19614568 DOI: 10.1042/Bst0370627  1
2009 Johnson LN. Protein kinase inhibitors: contributions from structure to clinical compounds. Quarterly Reviews of Biophysics. 42: 1-40. PMID 19296866 DOI: 10.1017/S0033583508004745  1
2009 Vénien-Bryan C, Jonic S, Skamnaki V, Brown N, Bischler N, Oikonomakos NG, Boisset N, Johnson LN. The structure of phosphorylase kinase holoenzyme at 9.9 angstroms resolution and location of the catalytic subunit and the substrate glycogen phosphorylase. Structure (London, England : 1993). 17: 117-27. PMID 19141288 DOI: 10.1016/J.Str.2008.10.013  1
2009 Davies KM, Lowe ED, Vénien-Bryan C, Johnson LN. The HupR receiver domain crystal structure in its nonphospho and inhibitory phospho states. Journal of Molecular Biology. 385: 51-64. PMID 18977359 DOI: 10.1016/J.Jmb.2008.10.027  1
2008 Lowe ED, Gao GY, Johnson LN, Keung WM. Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase. Journal of Medicinal Chemistry. 51: 4482-7. PMID 18613661 DOI: 10.1021/Jm800488J  1
2008 Baumli S, Lolli G, Lowe ED, Troiani S, Rusconi L, Bullock AN, Debreczeni JE, Knapp S, Johnson LN. The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. The Embo Journal. 27: 1907-18. PMID 18566585 DOI: 10.1038/Emboj.2008.121  1
2008 Johnson LN. Early days of structural biology. Cellular and Molecular Life Sciences : Cmls. 65: 2271-6. PMID 18516493 DOI: 10.1007/S00018-008-8272-2  1
2008 Johnson TM, Antrobus R, Johnson LN. Plk1 activation by Ste20-like kinase (Slk) phosphorylation and polo-box phosphopeptide binding assayed with the substrate translationally controlled tumor protein (TCTP). Biochemistry. 47: 3688-96. PMID 18298087 DOI: 10.1021/Bi702134C  1
2007 Brown NR, Lowe ED, Petri E, Skamnaki V, Antrobus R, Johnson LN. Cyclin B and cyclin A confer different substrate recognition properties on CDK2. Cell Cycle (Georgetown, Tex.). 6: 1350-9. PMID 17495531 DOI: 10.4161/Cc.6.11.4278  1
2007 Lolli G, Johnson LN. Recognition of Cdk2 by Cdk7. Proteins. 67: 1048-59. PMID 17373709 DOI: 10.1002/Prot.21370  1
2007 Johnson L. Protein kinases and their therapeutic exploitation Biochemical Society Transactions. 35: 7-11. PMID 17212579 DOI: 10.1042/Bst0350007  1
2006 Cheng KY, Noble ME, Skamnaki V, Brown NR, Lowe ED, Kontogiannis L, Shen K, Cole PA, Siligardi G, Johnson LN. The role of the phospho-CDK2/cyclin A recruitment site in substrate recognition. The Journal of Biological Chemistry. 281: 23167-79. PMID 16707497 DOI: 10.1074/Jbc.M600480200  1
2006 Davies KM, Skamnaki V, Johnson LN, Vénien-Bryan C. Structural and functional studies of the response regulator HupR. Journal of Molecular Biology. 359: 276-88. PMID 16631791 DOI: 10.1016/J.Jmb.2006.02.072  1
2006 Geremia S, Campagnolo M, Demitri N, Johnson LN. Simulation of diffusion time of small molecules in protein crystals. Structure (London, England : 1993). 14: 393-400. PMID 16531224 DOI: 10.1016/J.Str.2005.12.007  1
2006 Seeger JD, West WA, Fife D, Noel GJ, Johnson LN, Walker AM. Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. Pharmacoepidemiology and Drug Safety. 15: 784-92. PMID 16456878 DOI: 10.1002/pds.1214  0.01
2006 Lowe ED, Hasan N, Trempe JF, Fonso L, Noble ME, Endicott JA, Johnson LN, Brown NR. Structures of the Dsk2 UBL and UBA domains and their complex. Acta Crystallographica. Section D, Biological Crystallography. 62: 177-88. PMID 16421449 DOI: 10.1107/S0907444905037777  1
2006 Blake CCF, Fenn RH, Johnson LN, Koenig DF, Mair GA, North ACT, Oldham JWH, Phillips DC, Poljak RJ, Sarma VR, Vernon CA. How the structure of lysozyme was actually determined International Tables For Crystallography. DOI: 10.1107/97809553602060000725  1
2005 Passmore LA, Booth CR, Vénien-Bryan C, Ludtke SJ, Fioretto C, Johnson LN, Chiu W, Barford D. Structural analysis of the anaphase-promoting complex reveals multiple active sites and insights into polyubiquitylation. Molecular Cell. 20: 855-66. PMID 16364911 DOI: 10.1016/J.Molcel.2005.11.003  1
2005 Noble M, Barrett P, Endicott J, Johnson L, McDonnell J, Robertson G, Zawaira A. Exploiting structural principles to design cyclin-dependent kinase inhibitors. Biochimica Et Biophysica Acta. 1754: 58-64. PMID 16361058 DOI: 10.1016/J.Bbapap.2005.08.019  1
2005 Kuo A, Domene C, Johnson LN, Doyle DA, Vénien-Bryan C. Two different conformational states of the KirBac3.1 potassium channel revealed by electron crystallography. Structure (London, England : 1993). 13: 1463-72. PMID 16216578 DOI: 10.1016/J.Str.2005.07.011  1
2005 Lolli G, Johnson LN. CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs? Cell Cycle (Georgetown, Tex.). 4: 572-7. PMID 15876871 DOI: 10.4161/Cc.4.4.1607  1
2005 Cook AG, Johnson LN, McDonnell JM. Structural characterization of Ca2+/CaM in complex with the phosphorylase kinase PhK5 peptide. The Febs Journal. 272: 1511-22. PMID 15752366 DOI: 10.1111/J.1742-4658.2005.04591.X  1
2005 Honda R, Lowe ED, Dubinina E, Skamnaki V, Cook A, Brown NR, Johnson LN. The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2-independent roles. The Embo Journal. 24: 452-63. PMID 15660127 DOI: 10.1038/Sj.Emboj.7600554  1
2005 Wilson CC, Myles D, Ghosh M, Johnson LN, Wang W. Neutron diffraction investigations of L- and D-alanine at different temperatures: The search for structural evidence for parity violation New Journal of Chemistry. 29: 1318-1322. DOI: 10.1039/B419295H  1
2005 Johnson LN. Asymmetry at the molecular level in biology European Review. 13: 77-95. DOI: 10.1017/S1062798705000670  1
2004 Lolli G, Lowe ED, Brown NR, Johnson LN. The crystal structure of human CDK7 and its protein recognition properties. Structure (London, England : 1993). 12: 2067-79. PMID 15530371 DOI: 10.1016/J.Str.2004.08.013  1
2004 Noble ME, Endicott JA, Johnson LN. Protein kinase inhibitors: insights into drug design from structure. Science (New York, N.Y.). 303: 1800-5. PMID 15031492 DOI: 10.1126/Science.1095920  1
2003 Cheng KY, Lowe ED, Sinclair J, Nigg EA, Johnson LN. The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex. The Embo Journal. 22: 5757-68. PMID 14592974 DOI: 10.1093/Emboj/Cdg558  1
2003 De Moliner E, Brown NR, Johnson LN. Alternative binding modes of an inhibitor to two different kinases. European Journal of Biochemistry / Febs. 270: 3174-81. PMID 12869192 DOI: 10.1046/J.1432-1033.2003.03697.X  1
2003 Mesguiche V, Parsons RJ, Arris CE, Bentley J, Boyle FT, Curtin NJ, Davies TG, Endicott JA, Gibson AE, Golding BT, Griffin RJ, Jewsbury P, Johnson LN, Newell DR, Noble ME, et al. 4-Alkoxy-2,6-diaminopyrimidine derivatives: inhibitors of cyclin dependent kinases 1 and 2. Bioorganic & Medicinal Chemistry Letters. 13: 217-22. PMID 12482427 DOI: 10.1016/S0960-894X(02)00884-3  1
2002 Lowe ED, Tews I, Cheng KY, Brown NR, Gul S, Noble ME, Gamblin SJ, Johnson LN. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A. Biochemistry. 41: 15625-34. PMID 12501191 DOI: 10.1021/Bi0268910  0.96
2002 Davies TG, Bentley J, Arris CE, Boyle FT, Curtin NJ, Endicott JA, Gibson AE, Golding BT, Griffin RJ, Hardcastle IR, Jewsbury P, Johnson LN, Mesguiche V, Newell DR, Noble ME, et al. Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor. Nature Structural Biology. 9: 745-9. PMID 12244298 DOI: 10.1038/Nsb842  1
2002 Geremia S, Campagnolo M, Schinzel R, Johnson LN. Enzymatic catalysis in crystals of Escherichia coli maltodextrin phosphorylase. Journal of Molecular Biology. 322: 413-23. PMID 12217700 DOI: 10.1016/S0022-2836(02)00771-4  1
2002 Davies TG, Pratt DJ, Endicott JA, Johnson LN, Noble ME. Structure-based design of cyclin-dependent kinase inhibitors. Pharmacology & Therapeutics. 93: 125-33. PMID 12191605 DOI: 10.1016/S0163-7258(02)00182-1  1
2002 Johnson LN, De Moliner E, Brown NR, Song H, Barford D, Endicott JA, Noble ME. Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2. Pharmacology & Therapeutics. 93: 113-24. PMID 12191604 DOI: 10.1016/S0163-7258(02)00181-X  1
2002 Gibson AE, Arris CE, Bentley J, Boyle FT, Curtin NJ, Davies TG, Endicott JA, Golding BT, Grant S, Griffin RJ, Jewsbury P, Johnson LN, Mesguiche V, Newell DR, Noble ME, et al. Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives. Journal of Medicinal Chemistry. 45: 3381-93. PMID 12139449 DOI: 10.1021/Jm020056Z  1
2002 Cook A, Lowe ED, Chrysina ED, Skamnaki VT, Oikonomakos NG, Johnson LN. Structural studies on phospho-CDK2/cyclin A bound to nitrate, a transition state analogue: implications for the protein kinase mechanism. Biochemistry. 41: 7301-11. PMID 12044161 DOI: 10.1021/Bi0201724  1
2002 Vénien-Bryan C, Lowe EM, Boisset N, Traxler KW, Johnson LN, Carlson GM. Three-dimensional structure of phosphorylase kinase at 22 A resolution and its complex with glycogen phosphorylase b. Structure (London, England : 1993). 10: 33-41. PMID 11796108 DOI: 10.1016/S0969-2126(01)00691-8  1
2002 van Thor JJ, Gensch T, Hellingwerf KJ, Johnson LN. Phototransformation of green fluorescent protein with UV and visible light leads to decarboxylation of glutamate 222. Nature Structural Biology. 9: 37-41. PMID 11740505 DOI: 10.1038/Nsb739  1
2001 Johnson LN, Lewis RJ. Structural basis for control by phosphorylation. Chemical Reviews. 101: 2209-42. PMID 11749371 DOI: 10.1021/Cr000225S  1
2001 Lawrie AM, Tito P, Hernandez H, Brown NR, Robinson CV, Endicott JA, Noble ME, Johnson LN. Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells. Protein Expression and Purification. 23: 252-60. PMID 11676600 DOI: 10.1006/Prep.2001.1504  1
2001 Song H, Hanlon N, Brown NR, Noble ME, Johnson LN, Barford D. Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2. Molecular Cell. 7: 615-26. PMID 11463386 DOI: 10.1016/S1097-2765(01)00208-8  1
2001 Johnson LN. Structural basis for substrate recognition and control in protein kinases. Ernst Schering Research Foundation Workshop. 47-69. PMID 11394047  1
2000 Ghosh M, Meerts IA, Cook A, Bergman A, Brouwer A, Johnson LN. Structure of human transthyretin complexed with bromophenols: a new mode of binding. Acta Crystallographica. Section D, Biological Crystallography. 56: 1085-95. PMID 10957627 DOI: 10.1107/S0907444900008568  1
2000 Arris CE, Boyle FT, Calvert AH, Curtin NJ, Endicott JA, Garman EF, Gibson AE, Golding BT, Grant S, Griffin RJ, Jewsbury P, Johnson LN, Lawrie AM, Newell DR, Noble ME, et al. Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. Journal of Medicinal Chemistry. 43: 2797-804. PMID 10956187 DOI: 10.1021/Jm990628O  1
2000 Oikonomakos NG, Schnier JB, Zographos SE, Skamnaki VT, Tsitsanou KE, Johnson LN. Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site. The Journal of Biological Chemistry. 275: 34566-73. PMID 10924512 DOI: 10.1074/Jbc.M004485200  1
2000 Oikonomakos NG, Skamnaki VT, Tsitsanou KE, Gavalas NG, Johnson LN. A new allosteric site in glycogen phosphorylase b as a target for drug interactions. Structure (London, England : 1993). 8: 575-84. PMID 10873856 DOI: 10.1016/S0969-2126(00)00144-1  1
2000 Johnson LN. Present tributes to achievements past Structure (London, England : 1993). 8: R111-2. PMID 10801500 DOI: 10.1016/S0969-2126(00)00140-4  1
2000 Stubbe J, Johnson LN. Catalysis and regulation clarity through structures: Editorial overview Current Opinion in Structural Biology. 10: 709-710. DOI: 10.1016/S0959-440X(00)00160-3  1
1999 Brown NR, Noble ME, Endicott JA, Johnson LN. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nature Cell Biology. 1: 438-43. PMID 10559988 DOI: 10.1038/15674  1
1999 Skamnaki VT, Owen DJ, Noble ME, Lowe ED, Lowe G, Oikonomakos NG, Johnson LN. Catalytic mechanism of phosphorylase kinase probed by mutational studies. Biochemistry. 38: 14718-30. PMID 10545198 DOI: 10.1021/Bi991454F  1
1999 Watson KA, McCleverty C, Geremia S, Cottaz S, Driguez H, Johnson LN. Phosphorylase recognition and phosphorolysis of its oligosaccharide substrate: answers to a long outstanding question. The Embo Journal. 18: 4619-32. PMID 10469642 DOI: 10.1093/Emboj/18.17.4619  1
1999 Johnson LN, Petsko GA. David Phillips and the origin of structural enzymology Trends in Biochemical Sciences. 24: 287-289. PMID 10390620 DOI: 10.1016/S0968-0004(99)01423-1  1
1999 Johnson LN, Petsko GA. David Phillips (1924-99) Nature. 399: 26. PMID 10331385 DOI: 10.1038/19878  1
1999 O'Reilly M, Watson KA, Johnson LN. The crystal structure of the Escherichia coli maltodextrin phosphorylase-acarbose complex Biochemistry. 38: 5337-5345. PMID 10220320 DOI: 10.1021/Bi9828573  1
1999 Tsitsanou KE, Oikonomakos NG, Zographos SE, Skamnaki VT, Gregoriou M, Watson KA, Johnson LN, Fleet GW. Effects of commonly used cryoprotectants on glycogen phosphorylase activity and structure. Protein Science : a Publication of the Protein Society. 8: 741-9. PMID 10211820 DOI: 10.1110/Ps.8.4.741  1
1999 Brown NR, Noble ME, Lawrie AM, Morris MC, Tunnah P, Divita G, Johnson LN, Endicott JA. Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity. The Journal of Biological Chemistry. 274: 8746-56. PMID 10085115 DOI: 10.1074/Jbc.274.13.8746  1
1999 Johnson LN, Noble MEM, Barford D, Brown N, Endicott JA, Lawrie A, Owen DJ. Signal Transduction Proteins: Structural Basis of Control by Phosphorylation Journal of Chemical Society of Pakistan. 21: 185-201.  1
1998 Johnson LN. The early history of lysozyme Nature Structural Biology. 5: 942-944. PMID 9808036 DOI: 10.1038/2917  1
1998 Johnson LN, Lowe ED, Noble ME, Owen DJ. The Eleventh Datta Lecture. The structural basis for substrate recognition and control by protein kinases Febs Letters. 430: 1-11. PMID 9678585 DOI: 10.1016/S0014-5793(98)00606-1  1
1998 Gregoriou M, Noble ME, Watson KA, Garman EF, Krulle TM, de la Fuente C, Fleet GW, Oikonomakos NG, Johnson LN. The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100 K: the role of the water structure and its contribution to binding. Protein Science : a Publication of the Protein Society. 7: 915-27. PMID 9568898 DOI: 10.1002/Pro.5560070409  1
1998 Endicott J, Noble M, Lawrie A, Tunnah P, Brown N, Johnson L, Calvert A, Curtin N, Golding B, Griffin R, Newell. Insights into CDK inhibitor design from X-ray crystallographic studies Annals of Oncology. DOI: 10.1093/Annonc/9.Suppl_2.3  0.72
1998 Grant S, Boyle F, Calvert A, Curtin N, Endicott J, Golding B, Griffin R, Johnson L, Newell, Noble M, Robson C. O-6-alkylguanines as selective inhibitors of cyclin dependent kinases Annals of Oncology. DOI: 10.1093/Annonc/9.Suppl_2.132  0.72
1998 Stubbe J, Johnson LN. Catalysis and regulation. Channels, terpenes and phosphates Current Opinion in Structural Biology. 8: 675-678. DOI: 10.1016/S0959-440X(98)80085-7  1
1998 Johnson LN, Lowe ED, Noble MEM, Owen DJ. The structural basis for substrate recognition and control by protein kinases Febs Letters. 430: 1-11. DOI: 10.1016/S0014-5793(98)00606-1  1
1998 Fleet GWJ, Estevez JC, Smith MD, Blériot Y, De La Fuente C, Krülle TM, Besra GS, Brennan PJ, Nash RJ, Johnson LN, Oikonomakos NG, Stalmans W. Sugar mimics from sugar lactones Pure and Applied Chemistry. 70: 279-284.  1
1997 Noble ME, Endicott JA, Brown NR, Johnson LN. The cyclin box fold: protein recognition in cell-cycle and transcription control. Trends in Biochemical Sciences. 22: 482-7. PMID 9433129 DOI: 10.1016/S0968-0004(97)01144-4  1
1997 Zographos SE, Oikonomakos NG, Tsitsanou KE, Leonidas DD, Chrysina ED, Skamnaki VT, Bischoff H, Goldmann S, Watson KA, Johnson LN. The structure of glycogen phosphorylase b with an alkyl-dihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor Structure. 5: 1413-1425. PMID 9384557 DOI: 10.1016/S0969-2126(97)00292-X  1
1997 Lowe ED, Noble MEM, Skamnaki VT, Oikonomakos NG, Owen DJ, Johnson LN. The crystal structure of a phosphorylase kinase peptide substrate complex: Kinase substrate recognition Embo Journal. 16: 6646-6658. PMID 9362479 DOI: 10.1093/Emboj/16.22.6646  1
1997 Lawrie AM, Noble ME, Tunnah P, Brown NR, Johnson LN, Endicott JA. Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2. Nature Structural Biology. 4: 796-801. PMID 9334743 DOI: 10.1038/Nsb1097-796  0.6
1997 O'Reilly M, Watson KA, Schinzel R, Palm D, Johnson LN. Oligosaccharide substrate binding in Escherichia coli maltodextrin phosphorylase Nature Structural Biology. 4: 405-412. PMID 9145112 DOI: 10.1038/Nsb0597-405  1
1997 Watson KA, Schinzel R, Palm D, Johnson LN. The crystal structure of Escherichia coli maltodextrin phosphorylase provides an explanation for the activity without control in this basic archetype of a phosphorylase Embo Journal. 16: 1-14. PMID 9009262 DOI: 10.1093/Emboj/16.1.1  1
1997 De La Fuente C, Krülle TM, Watson KA, Gregoriou M, Johnson LN, Tsitsanou KE, Zographos SE, Oikonomakos NG, Fleet GWJ. Glucopyranose spirohydantoins: Specific inhibitors of glycogen phosphorylase Synlett. 485-487. DOI: 10.1055/S-1997-940277  1
1997 Krülle TM, De La Fuente C, Watson KA, Gregoriou M, Johnson LN, Tsitsanou KE, Zographos SE, Oikonomakos NG, Fleet GWJ. Stereospecific Synthesis of Spirohydantoins of β-Glucopyranose: Inhibitors of Glycogen Phosphorylase Synlett. 1997: 211-213. DOI: 10.1055/S-1997-736  1
1997 Johnson LN, Barford D, Owen DJ, Noble MEM, Garman EF. From phosphorylase to phosphorylase kinase. Advances in Second Messenger and Phosphoprotein Research. 31: 11-28. DOI: 10.1007/978-3-642-60848-3_2  0.72
1997 Johnson LN, Brown NR, Endicoti JA, Lawrie AM, Löwe ED, Noble MEM, Tunnah P. The structural basis for control by phosphorylation Faseb Journal. 11: A1011.  1
1996 Johnson LN, O'Reilly M. Control by phosphorylation Current Opinion in Structural Biology. 6: 762-769. PMID 8994876 DOI: 10.1016/S0959-440X(96)80005-4  1
1996 Oikonomakos NG, Zographos SE, Tsitsanou KE, Johnson LN, Acharya KR. Activator anion binding site in pyridoxal phosphorylase b: The binding of phosphite, phosphate, and fluorophosphate in the crystal Protein Science. 5: 2416-2428. PMID 8976550 DOI: 10.1002/Pro.5560051204  1
1996 Mitchell EP, Withers SG, Ermert P, Vasella AT, Garman EF, Oikonomakos NG, Johnson LN. Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states. Biochemistry. 35: 7341-55. PMID 8652510 DOI: 10.1021/Bi960072W  1
1996 Johnson LN, Noble MEM, Owen DJ. Active and inactive protein kinases: Structural basis for regulation Cell. 85: 149-158. PMID 8612268 DOI: 10.1016/S0092-8674(00)81092-2  1
1996 Blériot Y, Smelt KH, Cadefau J, Bollen M, Stalmans W, Biggadike K, Johnson LN, Oikonomakos NG, Lane AL, Crook S, Watkin DJ, Fleet GWJ. 7-Carbon mimics of D-glucose and L-fucose: Activation of 6R-, and inactivation of 6S-, -6C-methylglucose of glycogen synthase: Inhibition of glucokinase and/or glucose-6-phosphatase Tetrahedron Letters. 37: 7155-7158. DOI: 10.1016/0040-4039(96)01565-1  1
1996 Brandstetter TW, De La Fuente C, Kim Yh, Johnson LN, Crook S, Paul PM, Watkin DJ, Tsitsanou KE, Zographos SE, Chrysina ED, Oikonomakos NG, Fleet GWJ. Glucofuranose analogues of hydantocidin Tetrahedron. 52: 10721-10736. DOI: 10.1016/0040-4020(96)00595-9  1
1996 Brandstetter TW, De La Fuente C, Kim YH, Cooper RI, Watkin DJ, Oikonomakos NG, Johnson LN, Fleet GWJ. α-Azidoesters as divergent intermediates for combinatorial generation of glucofuranose libraries of novel N-linked glycopeptides Tetrahedron. 52: 10711-10720. DOI: 10.1016/0040-4020(96)00594-7  1
1995 Watson KA, Mitchell EP, Johnson LN, Cruciani G, Son JC, Bichard CJ, Fleet GW, Oikonomakos NG, Kontou M, Zographos SE. Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection. Acta Crystallographica. Section D, Biological Crystallography. 51: 458-72. PMID 15299833 DOI: 10.1107/S090744499401348X  0.4
1995 Brown NR, Noble ME, Endicott JA, Garman EF, Wakatsuki S, Mitchell E, Rasmussen B, Hunt T, Johnson LN. The crystal structure of cyclin A. Structure (London, England : 1993). 3: 1235-47. PMID 8591034 DOI: 10.1016/S0969-2126(01)00259-3  0.72
1995 Oikonomakos NG, Kontou M, Zographos SE, Watson KA, Johnson LN, Bichard CJF, Fleet GWJ, Acharya KR. N-acetyl-β-d-glucopyranosylamine: A potent T-state inhibitor of glycogen phosphorylase. A comparison with α-D-glucose Protein Science. 4: 2469-2477. PMID 8580837 DOI: 10.1002/Pro.5560041203  1
1995 Duke EM, Wakatsuki S, Hadfield A, Johnson LN. Laue and monochromatic diffraction studies on catalysis in phosphorylase b crystals. Protein Science : a Publication of the Protein Society. 3: 1178-96. PMID 7987213 DOI: 10.1002/Pro.5560030804  0.32
1995 Endicott JA, Noble ME, Garman EF, Brown N, Rasmussen B, Nurse P, Johnson LN. The crystal structure of p13suc1, a p34cdc2-interacting cell cycle control protein Embo Journal. 14: 1004-1014. PMID 7889931 DOI: 10.1002/J.1460-2075.1995.Tb07081.X  1
1995 Owen DJ, Papageorgiou AC, Garman EF, Noble MEM, Johnson LN. Expression, purification and crystallisation of phosphorylase kinase catalytic domain Journal of Molecular Biology. 246: 374-381. PMID 7877161 DOI: 10.1006/Jmbi.1994.0092  0.72
1995 Johnson LN. Virology institute changes direction [2] Nature. 375: 351. PMID 7760919 DOI: 10.1038/375351B0  1
1995 Board M, Hadwen M, Johnson LN. Effects of novel analogues of D-glucose on glycogen phosphorylase activities in crude extracts of liver and skeletal muscle European Journal of Biochemistry. 228: 753-761. PMID 7737174 DOI: 10.1111/J.1432-1033.1995.0753M.X  1
1995 Owen DJ, Noble M, Garman EF, Papageorigiou AC, Johnson LN. Two structures of the catalytic domain of phosphorylase kinase: an active protein kinase complexed with substrate analogue and product Structure. 3: 467-482. PMID 7663944 DOI: 10.1016/S0969-2126(01)00180-0  0.72
1995 Zographos SE, Oikonomakos NG, Dixon HB, Griffin WG, Johnson LN, Leonidas DD. Sulphate-activated phosphorylase b: the pH-dependence of catalytic activity. The Biochemical Journal. 310: 565-70. PMID 7654195 DOI: 10.1042/Bj3100565  1
1995 Oikonomakos NG, Zographos SE, Johnson LN, Papageorgiou AC, Acharya KR. The binding of 2-deoxy-o-glucose 6-phosphate to glycogen phosphorylase b: Kinetic and crystallographic studies Journal of Molecular Biology. 254: 900-917. PMID 7500360 DOI: 10.1006/Jmbi.1995.0665  1
1995 Board M, Bollen M, Stalmans W, Kim Y, Fleet GWJ, Johnson LN. Effects of C-1-substituted glucose analogue on the activation states of glycogen synthase and glycogen phosphorylase in rat hepatocytes Biochemical Journal. 311: 845-852. PMID 7487940 DOI: 10.1042/Bj3110845  1
1995 Bourne Y, Arvai AS, Bernstein SL, Watson MH, Reed SI, Endicott JE, Noble ME, Johnson LN, Tainer JA. Crystal structure of the cell cycle-regulatory protein suc1 reveals a β- hinge conformational switch Proceedings of the National Academy of Sciences of the United States of America. 92: 10232-10236. PMID 7479758 DOI: 10.1073/Pnas.92.22.10232  1
1995 Krülle TM, Watson KA, Gregoriou M, Johnson LN, Crook S, Watkin DJ, Griffiths RC, Nash RJ, Tsitsanou KE, Zographos SE, Oikonomakos NG, Fleet GWJ. Specific inhibition of glycogen phosphorylase by a spirodiketopiperazine at the anomeric position of glucopyranose Tetrahedron Letters. 36: 8291-8294. DOI: 10.1016/0040-4039(95)01733-X  1
1995 Brandstetter TW, Kim Yh, Son JC, Taylor HM, Paul PM, Watkin DJ, Johnson LN, Oikonomakos NG, Fleet GWJ. Spirohydantoins of glucofuranose: Analogues of hydantocidin Tetrahedron Letters. 36: 2149-2152. DOI: 10.1016/0040-4039(95)00198-L  1
1995 Bichard CJF, Mitchell EP, Wormald MR, Watson KA, Johnson LN, Zographos SE, Koutra DD, Oikonomakos NG, Fleet GWJ. Potent inhibition of glycogen phosphorylase by a spirohydantoin of glucopyranose: First pyranose analogues of hydantocidin Tetrahedron Letters. 36: 2145-2148. DOI: 10.1016/0040-4039(95)00197-K  1
1994 Noble ME, Cleasby A, Johnson LN, Egmond MR, Frenken LG. Analysis of the structure of Pseudomonas glumae lipase. Protein Engineering. 7: 559-62. PMID 8029212 DOI: 10.1093/Protein/7.4.559  0.4
1994 Hadfield AT, Harvey DJ, Archer DB, MacKenzie DA, Jeenes DJ, Radford SE, Lowe G, Dobson CM, Johnson LN. Crystal structure of the mutant D52S hen egg white lysozyme with an oligosaccharide product Journal of Molecular Biology. 243: 856-872. PMID 7966306 DOI: 10.1006/Jmbi.1994.1688  1
1994 Oikonomakos NG, Kontou M, Zographos SE, Tsitoura HS, Johnson LN, Watson KA, Mitchell EP, Fleet GW, Son JC, Bichard CJ. The design of potential antidiabetic drugs: experimental investigation of a number of beta-D-glucose analogue inhibitors of glycogen phosphorylase. European Journal of Drug Metabolism and Pharmacokinetics. 19: 185-92. PMID 7867660 DOI: 10.1007/Bf03188920  1
1994 Johnson LN. Professor Dorothy Hodgkin, OM, FRS. 1910-1994 Nature Structural Biology. 1: 573-576. PMID 7634095 DOI: 10.1038/nsb0994-573  1
1994 Johnson LN. Control by protein phosphorylation Nature Structural Biology. 1: 657-659. PMID 7634063 DOI: 10.1038/Nsb1094-657  1
1994 Oikonomakos NG, Kontou M, Zographos SE, Koutra DD, Johnson LN, Watson KA, Mitchell EP, Fleet GWJ, Son JC, Bichard CJF. The design of potential antidiabetic drugs: β-D-glucose analogue inhibitors of glycogen phosphorylase Epitheorese Klinikes Farmakologias Kai Farmakokinetikes. 12: 103-122.  1
1993 Noble ME, Cleasby A, Johnson LN, Egmond MR, Frenken LG. The crystal structure of triacylglycerol lipase from Pseudomonas glumae reveals a partially redundant catalytic aspartate. Febs Letters. 331: 123-8. PMID 8405390 DOI: 10.1016/0014-5793(93)80310-Q  0.32
1993 Johnson LN, Snape P, Martin JL, Acharya KR, Barford D, Oikonomakos NG. Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b Journal of Molecular Biology. 232: 253-267. PMID 8331662 DOI: 10.1006/Jmbi.1993.1380  1
1993 Watson KA, Mitchell EP, Johnson LN, Son JC, Bichard CJF, Fleet GWJ, Ford P, Watkin DJ, Oikonomakos NG. X-Ray crystallographic analysis of 2,6-anhydro-N-methyl-D-glycero-D-ido- heptonamide: The first example of a simple glucose analogue with a skew boat structure Journal of the Chemical Society, Chemical Communications. 654-656. DOI: 10.1039/C39930000654  1
1992 Duke EMH, Hadfield A, Walters S, Wakatsuki S, Bryan RK, Johnson LN. Time-resolved diffraction studies on glycogen phosphorylase b Philosophical Transactions of the Royal Society A. 340: 245-261. DOI: 10.1098/Rsta.1992.0064  0.4
1991 Duke EM, Hadfield A, Martin JL, Clifton IJ, Hajdu J, Johnson LN, Reid GP, Trentham DR, Bruce I, Fleet GW. Towards time-resolved diffraction studies with glycogen phosphorylase. Ciba Foundation Symposium. 161: 75-86; discussion 86. PMID 1814698 DOI: 10.1002/9780470514146.ch6  1
1990 Hajdu J, Johnson LN. Progress with Laue diffraction studies on protein and virus crystals. Biochemistry. 29: 1669-78. PMID 2184884 DOI: 10.1021/Bi00459A001  0.64
1990 Johnson LN, Acharya KR, Jordan MD, McLaughlin PJ. Refined crystal structure of the phosphorylase-heptulose 2-phosphate-oligosaccharide-AMP complex. Journal of Molecular Biology. 211: 645-61. PMID 2106586 DOI: 10.1016/0022-2836(90)90271-M  1
1989 Oikonomakos NG, Acharya KR, Melpidou AE, Stuart DI, Johnson LN. The binding of β-glycerophosphate to glycogen phosphorylase b in the crystal Archives of Biochemistry and Biophysics. 270: 62-68. PMID 2494945 DOI: 10.1016/0003-9861(89)90007-6  1
1988 Oikonomakos NG, Acharya KR, Stuart DI, Melpidou AE, McLaughlin PJ, Johnson LN. Uridine(5')diphospho(1)-alpha-D-glucose. A binding study to glycogen phosphorylase b in the crystal European Journal of Biochemistry. 173: 569-578. PMID 3371347 DOI: 10.1111/J.1432-1033.1988.Tb14037.X  1
1988 Dombrádi V, Willis AC, Vereb G, Johnson LN. The sequence around the phosphorylation site of the porcine heart type phosphorylase isoenzyme Comparative Biochemistry and Physiology -- Part B: Biochemistry And. 91: 717-721. PMID 3224509 DOI: 10.1016/0305-0491(88)90198-8  1
1988 Sprang SR, Acharya KR, Goldsmith EJ, Stuart DI, Varvill K, Fletterick RJ, Madsen NB, Johnson LN. Structural changes in glycogen phosphorylase induced by phosphorylation. Nature. 336: 215-21. PMID 3194008 DOI: 10.1038/336215A0  1
1988 Barford D, Schwabe JW, Oikonomakos NG, Acharya KR, Hajdu J, Papageorgiou AC, Martin JL, Knott JC, Vasella A, Johnson LN. Channels at the catalytic site of glycogen phosphorylase b: binding and kinetic studies with the beta-glycosidase inhibitor D-gluconohydroximo-1,5-lactone N-phenylurethane. Biochemistry. 27: 6733-41. PMID 3143403 DOI: 10.1021/Bi00418A014  0.64
1988 Hajdu J, Acharya KR, Stuart DI, Barford D, Johnson LN. Catalysis in enzyme crystals. Trends in Biochemical Sciences. 13: 104-9. PMID 3072704 DOI: 10.1016/0968-0004(88)90051-5  1
1988 Johnson LN, Cheetham J, McLaughlin PJ, Acharya KR, Barford D, Phillips DC. Protein-oligosaccharide interactions: lysozyme, phosphorylase, amylases. Current Topics in Microbiology and Immunology. 139: 81-134. PMID 2461836  1
1987 Oikonomakos NG, Johnson LN, Acharya KR, Stuart DI, Barford D, Hajdu J, Varvill KM, Melpidou AE, Papageorgiou T, Graves DJ. Pyridoxal phosphate site in glycogen phosphorylase b: structure in native enzyme and in three derivatives with modified cofactors. Biochemistry. 26: 8381-9. PMID 3126802 DOI: 10.1021/Bi00399A053  0.64
1987 Johnson LN, Acharya KR, Stuart DI, Barford D, Oikonomakos NG, Hajdu J, Varvill KM. Phosphate-recognition sites in catalysis and control of glycogen phosphorylase b. Biochemical Society Transactions. 15: 1001-5. PMID 3121407 DOI: 10.1042/Bst0151001  1
1987 Hajdu J, Machin PA, Campbell JW, Greenhough TJ, Clifton IJ, Zurek S, Gover S, Johnson LN, Elder M. Millisecond X-ray diffraction and the first electron density map from Laue photographs of a protein crystal. Nature. 329: 178-81. PMID 3114644 DOI: 10.1038/329178A0  1
1987 Hajdu J, Acharya KR, Stuart DI, McLaughlin PJ, Barford D, Oikonomakos NG, Klein H, Johnson LN. Catalysis in the crystal: synchrotron radiation studies with glycogen phosphorylase b. The Embo Journal. 6: 539-46. PMID 3107984 DOI: 10.1107/S0108767387084393  1
1986 Hajdu J, Acharya KR, Stuart DI, McLaughlin PJ, Barford D, Klein H, Johnson LN. Time-resolved structural studies on catalysis in the crystal with glycogen phosphorylase b. Biochemical Society Transactions. 14: 538-41. PMID 3089851 DOI: 10.1042/Bst0140538  1
1984 McLaughlin PJ, Stuart DI, Klein HW, Oikonomakos NG, Johnson LN. Substrate-cofactor interactions for glycogen phosphorylase b: a binding study in the crystal with heptenitol and heptulose 2-phosphate. Biochemistry. 23: 5862-73. PMID 6441595 DOI: 10.1021/Bi00319A028  0.4
1984 Sansom MS, Babu YS, Hajdu J, Stuart DI, Stura EA, Johnson LN. The role of pyridoxal phosphate in glycogen phosphorylase b; structure, environment and relationship to catalytic mechanism. Progress in Clinical and Biological Research. 144: 127-46. PMID 6427782  0.64
1984 Lorek A, Wilson KS, Sansom MS, Stuart DI, Stura EA, Jenkins JA, Zanotti G, Hajdu J, Johnson LN. Allosteric interactions of glycogen phosphorylase b. A crystallographic study of glucose 6-phosphate and inorganic phosphate binding to di-imidate-cross-linked phosphorylase b. The Biochemical Journal. 218: 45-60. PMID 6424657 DOI: 10.1042/Bj2180045  0.64
1981 Perkins SJ, Johnson LN, Phillips DC, Dwek RA. The simultaneous binding of lanthanide and N-acetylglucosamine inhibitors to hen egg-white lysozyme in solution by 1H and 13C nuclear magnetic resonance. The Biochemical Journal. 193: 573-88. PMID 7305947 DOI: 10.1042/Bj1930573  1
1981 Perkins SJ, Johnson LN, Phillips DC, Dwek RA. The binding of monosaccharide inhibitors to hen egg-white lysozyme by proton magnetic resonance at 270 MHz and analysis by ring-current calculations. The Biochemical Journal. 193: 553-72. PMID 7305946 DOI: 10.1042/Bj1930553  1
1981 Jenkins JA, Johnson LN, Stuart DI, Stura EA, Wilson KS, Zanotti G. Phosphorylase: control and activity. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 293: 23-41. PMID 6115421 DOI: 10.1098/rstb.1981.0057  0.4
1979 Perkins SJ, Johnson LN, Machin PA, Phillips DC. Crystal structures of hen egg-white lysozyme complexes with gadolinium(III) and gadolinium(III)-N-acetyl-D-glucosamine. The Biochemical Journal. 181: 21-36. PMID 486153 DOI: 10.1042/Bj1810021  1
1978 Perkins SJ, Johnson LN, Machin PA, Phillips DC. Crystal structures of egg-white lysozyme of hen in acetate-free medium and of lysozyme complexes with N-acetylglucosamine and beta-methyl N-acetylglucosaminide. The Biochemical Journal. 173: 607-16. PMID 697738 DOI: 10.1042/Bj1730607  1
1977 Eagles PA, Johnson LN, Van Horn C, Bullivant S. Freeze-fracture of adrenal chromaffin granules. Neuroscience. 2: 153-8. PMID 917273 DOI: 10.1016/0306-4522(77)90076-8  1
1977 Perkins SJ, Johnson LN, Phillips DC, Dwek RA. Conformational changes, dynamics and assignments in 1H NMR studies of proteins using ring current calculations. Hen egg white lysozyme. Febs Letters. 82: 17-22. PMID 562276 DOI: 10.1016/0014-5793(77)80876-4  1
1977 Blake CC, Grace DE, Johnson LN, Perkins SJ, Phillips DC, Cassels R, Dobson CM, Poulsen FM, Williams RJ. Physical and chemical properties of lysozyme. Ciba Foundation Symposium. 137-85. PMID 252451  1
1977 Perkins SJ, Johnson LN, Phillips DC, Dwek RA. High resolution 1H- and 13C-N.M.R spectra of D-glucopyranose, 2-acetamido-2-deoxy-D-glucopyranose, and related compounds in aqueous media Carbohydrate Research. 59: 19-34. DOI: 10.1016/S0008-6215(00)83289-9  1
1976 Bashford CL, Johnson LN, Radda GK, Ritchie GA. Lipid ordering and enzymic activities in chromaffin granule membranes European Journal of Biochemistry. 67: 105-114. PMID 134888 DOI: 10.1111/J.1432-1033.1976.Tb10638.X  1
1976 Eagles PA, Johnson LN, Van Horn C. The distribution of anionic sites on the surface of the chromaffin granule membrane. Journal of Ultrastructure Research. 55: 87-95. PMID 57247 DOI: 10.1016/S0022-5320(76)80084-6  1
1976 Fletterick RJ, Sygusch J, Murray N, Madsen NB, Johnson LN. Low-resolution structure of the glycogen phosphorylase a monomer and comparison with phosphorylase b Journal of Molecular Biology. 103: 1-13. DOI: 10.1016/0022-2836(76)90048-6  1
1974 Ford LO, Johnson LN, Machin PA, Phillips DC, Tjian R. Crystal structure of a lysozyme-tetrasaccharide lactone complex. Journal of Molecular Biology. 88: 349-71. PMID 4453000 DOI: 10.1016/0022-2836(74)90487-2  1
1974 Johnson LN, Madsen NB, Mosley J, Wilson KS. The crystal structure of phosphorylase beta at 6 A resolution. Journal of Molecular Biology. 90: 703-17. PMID 4449138 DOI: 10.1016/0022-2836(74)90534-8  1
1972 Eagles PAM, Johnson LN. Electron microscopy of phosphorylase b crystals Journal of Molecular Biology. 64. PMID 5022193 DOI: 10.1016/0022-2836(72)90092-7  1
1972 Eagles PAM, Iqbal M, Johnson LN, Mosley J, Wilson KS. A tetragonal crystal form of phosphorylase b Journal of Molecular Biology. 71. PMID 4648349 DOI: 10.1016/S0022-2836(72)80042-1  1
1972 Imoto T, Johnson LN, North ACT, Phillips DC, Rupley JA. 21 Vertebrate Lysozymes Enzymes. 7: 665-868. DOI: 10.1016/S1874-6047(08)60465-5  1
1969 Eagles PAM, Johnson LN, Joynson MA, McMurray CH, Gutfreund H. Subunit structure of aldolase: Chemical and crystallographic evidence Journal of Molecular Biology. 45. PMID 5394189 DOI: 10.1016/0022-2836(69)90310-6  1
1968 Johnson LN, Phillips DC, Rupley JA. The activity of lysozyme: an interim review of crystallographic and chemical evidence. Brookhaven Symposia in Biology. 21: 120-38. PMID 4889241  1
1967 Wyckoff HW, Doscher M, Tsernoglou D, Inagami T, Johnson LN, Hardman KD, Allewell NM, Kelly DM, Richards FM. Design of a diffractometer and flow cell system for X-ray analysis of crystalline proteins with applications to the crystal chemistry of ribonuclease-S. Journal of Molecular Biology. 27: 563-78. PMID 6049685 DOI: 10.1016/0022-2836(67)90059-9  1
1967 Wyckoff HW, Hardman KD, Allewell NM, Inagami T, Tsernoglou D, Johnson LN, Richards FM. The structure of ribonuclease-S at 6 A resolution. The Journal of Biological Chemistry. 242: 3749-53. PMID 6038503  1
1967 Wyckoff HW, Hardman KD, Allewell NM, Inagami T, Johnson LN, Richards FM. The structure of ribonuclease-S at 3.5 A resolution. The Journal of Biological Chemistry. 242: 3984-8. PMID 6037556  1
1967 Blake CC, Johnson LN, Mair GA, North AC, Phillips DC, Sarma VR. Crystallographic studies of the activity of hen egg-white lysozyme. Proceedings of the Royal Society of London. Series B, Biological Sciences. 167: 378-88. PMID 4382801 DOI: 10.1098/Rspb.1967.0035  1
1965 Johnson LN, Phillips DC. Structure of some crystalline lysozyme-inhibitor complexes determined by X-ray analysis at 6 Angstrom resolution. Nature. 206: 761-3. PMID 5840126 DOI: 10.1038/206761A0  1
1964 JOHNSON LN, PHILLIPS DC. CRYSTAL STRUCTURE OF N-ACETYLGLUCOSAMINE. Nature. 202: 588. PMID 14195059 DOI: 10.1038/202588A0  1
Show low-probability matches.